139 related articles for article (PubMed ID: 7528447)
1. Recombinant human granulocyte-macrophage colony-stimulating factor as adjunct to chemotherapy in aggressive non-Hodgkin's lymphomas.
Gerhartz HH; Engelhard M; Brittinger G; Schlimok G; Thiel E; Huber C; Emmerich B; Schadek C; Brandmaier R; Stern AC
Semin Oncol; 1994 Dec; 21(6 Suppl 16):25-8. PubMed ID: 7528447
[No Abstract] [Full Text] [Related]
2. MOPP/ABV/CAD chemotherapy with and without recombinant human granulocyte-macrophage colony stimulating factor in untreated, unfavorable prognosis Hodgkin's disease.
Riccardi A; Gobbi P; Danova M; Giordano M; Pieresca C; Bertoloni D; Brugnatelli S; Ascari E
Haematologica; 1993; 78(1):44-8. PubMed ID: 7684012
[TBL] [Abstract][Full Text] [Related]
3. Comparison of front-line chemotherapy for aggressive non-Hodgkin's lymphoma using the CAP-BOP regimens. The Nebraska Lymphoma Study Group.
Vose JM; Anderson JR; Bierman PJ; Bast M; Weisenburger D; Chan WC; Bishop MR; Armitage JO
Semin Hematol; 1994 Apr; 31(2 Suppl 3):4-8. PubMed ID: 7521065
[No Abstract] [Full Text] [Related]
4. Combination chemotherapy with COP-BLAM III for intermediate and high-grade non-Hodgkin's lymphoma.
Niitsu N; Umeda M
Int J Hematol; 1994 Jul; 60(1):71-8. PubMed ID: 7522616
[TBL] [Abstract][Full Text] [Related]
5. Granulocyte colony-stimulating factor (G-CSF) prevents dose-limiting neutropenia in lymphoma patients receiving standard dose chemotherapy.
Dotti G; Stella CC; Mangoni L; Cottafavi L; Caramatti C; Almici C; Rizzoli V
Haematologica; 1995; 80(2):142-5. PubMed ID: 7543069
[TBL] [Abstract][Full Text] [Related]
6. Cytokine efficiency in the treatment of high-grade malignant non-Hodgkin's lymphomas: results of a randomized double-blind placebo-controlled study with intensified COP-BLAM +/- rhGM-CSF.
Engelhard M; Gerhartz H; Brittinger G; Engert A; Fuchs R; Geiseler B; Gerhartz D; Haunauske AR; Hartlapp HJ; Huhn D
Ann Oncol; 1994; 5 Suppl 2():123-5. PubMed ID: 7515644
[TBL] [Abstract][Full Text] [Related]
7. [The chemoradiation treatment of patients with aggressive non-Hodgkin's lymphomas in the III-IV stages of the disease].
Sotnikov VM; Pan'shin GA; Pivnik AV; Grigor'eva MA
Ter Arkh; 1992; 64(7):54-6. PubMed ID: 1440370
[No Abstract] [Full Text] [Related]
8. [Treatment of malignant lymphoma: 12 years' experience with 109 patients. 2). Treatment of non-Hodgkin's lymphoma].
Furukawa Y; Takagi S; Tsuboyama A; Tsunoda S; Akashi M; Komatsu N; Takeda K; Muroi K; Akutsu M; Ohsaka A
Rinsho Ketsueki; 1987 Sep; 28(9):1544-52. PubMed ID: 3437516
[No Abstract] [Full Text] [Related]
9. Clinical trials referral resource. AIDS-related non-Hodgkin's lymphomas.
Cheson BD; Feigal EG
Oncology (Williston Park); 1993 Apr; 7(4):37-8. PubMed ID: 7683481
[No Abstract] [Full Text] [Related]
10. [Massive bilateral non-Hodgkin's lymphoma of the adrenal glands].
Arai N; Hara A; Umeda M; Shirai T
Rinsho Ketsueki; 1990 Sep; 31(9):1576-80. PubMed ID: 1701010
[TBL] [Abstract][Full Text] [Related]
11. [Lactic acidosis in non-Hodgkin's lymphoma].
Navigante AH; Chacón RD
Medicina (B Aires); 1985; 45(6):667-9. PubMed ID: 2431249
[No Abstract] [Full Text] [Related]
12. [Treatment by the CHOP protocol in malignant non-Hodgkin lymphomas with high malignancy].
Gociu M; Leahu S; Stoica I; Iofciulescu A; Berceanu S
Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1988; 40(1):47-51. PubMed ID: 2899347
[No Abstract] [Full Text] [Related]
13. COP-BLAM regimen combined with granulocyte colony-stimulating factor and high-grade non-Hodgkin's lymphoma.
Niitsu N; Umeda M
Eur J Haematol; 1995 Aug; 55(2):88-92. PubMed ID: 7543059
[TBL] [Abstract][Full Text] [Related]
14. [Studies of patients with non-Hodgkin's lymphoma unresponsive to C-MOPP].
Shirakawa S; Shimizu K; Shinkai K; Kojima H; Maruyama F; Sobue R; Ito N; Imura H; Matsui T; Ino T
Rinsho Ketsueki; 1988 Jul; 29(7):1025-30. PubMed ID: 3184470
[No Abstract] [Full Text] [Related]
15. [New therapy of patients with malignant lymphoma using G-CSF].
Asano S
Nihon Naika Gakkai Zasshi; 1994 Jun; 83(6):924-7. PubMed ID: 7525813
[No Abstract] [Full Text] [Related]
16. [Combined (poly-chemo-radio) therapy of non-Hodgkin's lymphomas].
Baĭsogolov GD; Shakhtarina SV; Polonskaia NIu; Davydov VA
Med Radiol (Mosk); 1989 Aug; 34(8):31-6. PubMed ID: 2770444
[No Abstract] [Full Text] [Related]
17. Serious pulmonary complications in patients receiving recombinant granulocyte colony-stimulating factor during BACOP chemotherapy for aggressive non-Hodgkin's lymphoma.
Lei KI; Leung WT; Johnson PJ
Br J Cancer; 1994 Nov; 70(5):1009-13. PubMed ID: 7524599
[TBL] [Abstract][Full Text] [Related]
18. CBVPM/AVBP versus HCOMLA chemotherapy in non-Hodgkin lymphoma patients.
Pawelski S; Konopka L; Pakulska J; Gutkowska J
Chemioterapia; 1987 Jun; 6(2 Suppl):716-9. PubMed ID: 2475265
[No Abstract] [Full Text] [Related]
19. Chemotherapy for Hodgkin's disease and aggressive non-Hodgkin's lymphoma. More is better, or is it?
Dodwell DJ; de Campos ES; Radford JA
Drugs; 1992 Jul; 44(1):1-8. PubMed ID: 1379906
[No Abstract] [Full Text] [Related]
20. German-Austrian multicenter trial for aggressive non-Hodgkin lymphomas: COP-BLAM/IMVP-16 chemotherapy with randomized adjuvant radiotherapy.
Gerhartz HH; Thiel E; Brittinger G; Dörken B; Engelhard M; Engert W; Enne W; Fuchs R; Hagen-Aukamp CH; Huhn D
Blut; 1988 Mar; 56(3):139-42. PubMed ID: 2451551
[No Abstract] [Full Text] [Related]
[Next] [New Search]
